Australia aims to lure foreign companies for medtech R&D (research and development)
This article was originally published in Clinica
Executive Summary
The Australian federal and state governments are openly trying to attract foreign businesses to the country by making the conditions for carrying out R&D more favourable. Australia currently imports 90% of the products that are used in the healthcare system, says Anthony Weymouth, a health and medical industry specialist for the Australian Trade Commission.